Redox signalling occurs when a biological system alters in response to a change in the level of a particular reactive oxygen species (ROS) or the shift in redox state of a responsive group such as a dithiol–disulphide couple (D'Autreaux and Toledano, 2007; Finkel, 2011; Fourquet et al., 2008; Janssen-Heininger et al., 2008; Rhee, 2006). Although ROS are best known as damaging agents in pathology, a more nuanced view has developed. It is now clear that some ROS, such as hydrogen peroxide (H2O2), can act as messengers both in the extracellular environment and within cells (D'Autreaux and Toledano, 2007; Fourquet et al., 2008; Janssen-Heininger et al., 2008; Rhee, 2006). Mitochondria seem to be an important redox signalling node, partly because of the flux of the ROS superoxide (O2·−) generated by the respiratory chain and other core metabolic machineries within mitochondria (Balaban et al., 2005; Finkel, 2011; Murphy, 2009a). In addition, the mitochondrial matrix is central to metabolism, as oxidative phosphorylation, the citric acid cycle, fatty acid oxidation, the urea cycle and the biosynthesis of iron sulphur centres and haem take place there. Furthermore, mitochondria have key roles in apoptosis, calcium homeostasis and oxygen sensing (Duchen, 2004; Murphy, 2009a; Murphy, 2009b). Consequently, mitochondria are at the core of many biological processes, and redox signals to and from this organelle help to integrate mitochondrial function with that of the cell and organism. In this Cell Science at a Glance article we outline how mitochondrial redox signals are produced and modulated, the mechanisms by which redox signals can alter mitochondrial function and the experimental procedures available to assess this.
Production and modulation of redox signals to and from mitochondria
The initial ROS formed within mitochondria is O2·−, which is generated by the respiratory chain and other enzymatic components within the mitochondrion (Finkel, 2011; Murphy, 2009a). Mitochondrial O2·− generation provides an indication of functional status because its production is altered by many cellular factors. These include the membrane potential, the reduction state of electron carriers and post-translational modification or damage to the respiratory chain (Murphy, 2009a). However, O2·− itself is not the main ROS signal within mitochondria because it is mostly converted to H2O2 by manganese superoxide dismutase (MnSOD), which reacts very rapidly with O2·− and is present at a high concentration within the matrix (Balaban et al., 2005; Chance et al., 1979; Finkel, 2005; Murphy, 2009a). As H2O2 can pass easily through mitochondrial membranes, it can act as a redox signal from mitochondria to the rest of the cell and vice versa (Balaban et al., 2005; D'Autreaux and Toledano, 2007; Droge, 2002; Fourquet et al., 2008; Janssen-Heininger et al., 2008; Murphy, 2009a).
Respiratory complex III can also release O2·− into the intermembrane space (St-Pierre et al., 2002; Muller et al., 2004; Han et al., 2001). The intermembrane space enzyme p66Shc (the 66 kDa isoform of the growth factor adapter Shc) can also generate O2·−, which can regulate apoptotic cell death (Giorgio et al., 2005). The O2·− can diffuse from the intermembrane space to the cytosol or be converted to H2O2 by an intermembrane space Cu,Zn-SOD (Okado-Matsumoto and Fridovich, 2001). The Mia40p and Erv1p system of the intermembrane space, which inserts disulphide bonds into intermembrane space proteins during import, also generates H2O2 (Koehler et al., 2006), but the potential of this for redox signalling is unclear.
Matrix H2O2 concentration is further regulated by degradation through peroxiredoxin 3 and 5 (Prx3 and Prx5, respectively) and glutathione peroxidase 1 (Gpx1), with Prx3 being the most significant because of its relative abundance and reactivity (Cox et al., 2010). Prx proteins degrade H2O2 using the mitochondrial thioredoxin 2 (Trx2) system as a reducing source, whereas Gpx1 uses the mitochondrial glutathione (GSH) pool (Cox et al., 2010). During its reaction cycle, dimeric Prx3 forms an inter-subunit disulphide that is reduced back to the dithiol form by Trx2 (Rhee, 2006; Rhee et al., 2001). Exposure to H2O2 can lead to a significant fraction of Prx3 being in the disulphide form at any given time, thereby affecting H2O2 release from mitochondria (Cox et al., 2009; Cox et al., 2008). The activity of Prx3 might also be affected by post-translational modification or by the extent of its oligomerisation (Rhee et al., 2001; Rhee et al., 2005b; Cox et al., 2010). The extent of this H2O2 signal can be modulated both by its production, which is highly responsive to mitochondrial status (Murphy, 2009a), and by the rate of its degradation by matrix peroxidases – predominantly Prx3 – and diffusion into and out of the organelle.
The H2O2 that is produced by one mitochondrion can diffuse to another, coordinating or relaying signals between the organelles (Murphy, 2009a). Additionally, H2O2 can diffuse to mitochondria from the cell surface through the activation of NADPH oxidase (NOX) enzymes by growth factors (Janssen-Heininger et al., 2008; Rhee et al., 2005a; Rhee et al., 2005b).
The main ROS involved in redox signalling to and from mitochondria seems to be H2O2; however, other forms of ROS can also contribute. Nitric oxide (NO) is generated by NO synthases, and can diffuse into mitochondria and modulate mitochondrial function by competing with O2 at respiratory complex IV – thereby slowing respiration – and by the S-nitrosation of mitochondrial thiol groups (Moncada and Erusalimsky, 2002). Iron sulphur centres in proteins such as aconitase can react rapidly with O2·− (D'Autreaux and Toledano, 2007), thereby modifying activity independently of H2O. In addition, O2·− can diffuse from the intermembrane space through the outer membrane voltage-dependent anion channel to the cytosol, where it can act as a redox signal (Zhou et al., 2010). However, as O2·− is shorter lived and less diffusible than H2O2, its signalling roles are thought to be more limited. A number of other redox signals might also be produced within mitochondria, including peroxynitrite (ONOO−) and the products of mitochondrial lipid peroxidation, such as prostaglandin-like molecules and 4-hydroxynonenal (HNE) (Levonen et al., 2004). These compounds can modify mitochondrial protein thiols and, thereby, affect their activity; however, the metabolic significance of these interactions is unclear.
Post-translational protein modification by H2O2 and NO
To act as effective biological messengers, molecules such as H2O2 and NO have to bring about a reversible change in the activity of a protein. Generally, this involves modification of a thiol group on a cysteine residue that mediates redox signalling (Eaton, 2006; Gilbert, 1990; Gilbert, 1995; Schafer and Buettner, 2001). For example, when H2O2 acts as a redox signal it oxidises the thiol group on the target protein to a disulphide group, thereby changing the function of the protein; once the level of H2O2 has returned to basal levels the alteration is reversed and the activity of the protein reverts to its initial level (Beltran et al., 2000; D'Autreaux and Toledano, 2007; Hess et al., 2001; Jacob et al., 2003; Janssen-Heininger et al., 2008; Ziegler, 1985). If the modification is to an active-site thiol, for example oxidation of the crucial thiol in tyrosine phosphatases (Boivin et al., 2010), then the impact on the protein is a clear loss of function. However, thiol oxidation can alter proteins and, thereby, mediate the redox signal in other ways, such as by changing binding affinity to another protein, altering its action as a transcription factor, or by modifying the activity of a transporter or channel (Balaban et al., 2005; D'Autreaux and Toledano, 2007; Droge, 2002; Fourquet et al., 2008; Murphy, 2009a; Rhee, 2006; Rhee et al., 2000).
Generally, in response to H2O2, protein thiol groups will initially form a sulphenic acid (−SOH) (Brennan et al., 2004; Charles et al., 2007; Cotgreave and Gerdes, 1998; Fratelli et al., 2004; Leonard et al., 2009; Seres et al., 1996; Ziegler, 1985; Dalle-Donne et al., 2008; Dalle-Donne et al., 2009), which can occur by direct reaction of H2O2 with the thiolate (−S−). This reaction is dependent on the local environment of the thiol and also its pKa, which can lead to certain thiols being particularly sensitive to oxidation. Once formed, the sulphenic acid can itself be a relevant post-translational modification, or it can form other post-translational modifications by reacting with a GSH to form a glutathionylated protein, with an adjacent thiol to form a disulphide (Brennan et al., 2004; Charles et al., 2007; Dalle-Donne et al., 2009; Delaunay et al., 2002; Hurd et al., 2008), or with amides within the protein to form a sulphenyl amide (Sivaramakrishnan et al., 2010). An alternative route to thiol oxidation during redox signalling is the single-electron oxidation of a thiol to a thiyl radical (−S·), which can then react to form disulphide bonds with GSH or with another protein thiol (Wardman and Von Sonntag, 1995; Winterbourn, 1993).
NO metabolism can also modify a protein thiol group into an S-nitrosothiol group (SNO) in a process known as S-nitrosation or S-nitrosylation (Beltran et al., 2000; Hess et al., 2001; Hogg, 2002; Stamler, 1994; Stamler and Hausladen, 1998). The mechanism of SNO formation in vivo is obscure (Hogg, 2002) but, once generated, the SNO can be passed between thiols by transnitrosation, with the formation and stability of the SNO determined by protein sequence motifs that surround the modified cysteine residue (Benhar et al., 2009; Doulias et al., 2010; Hou et al., 1996; Marino and Gladyshev, 2010; Nikitovic and Holmgren, 1996). In addition, an initial SNO on a protein can be modified into other thiol-based groups, such as disulphide, sulphenic acid or into a glutathionylated protein (Nikitovic and Holmgren, 1996; Stamler et al., 1992).
All of these post-translational modifications can potentially act as ‘redox switches’ (Cabiscol and Levine, 1996; Mallis et al., 2000; Schafer and Buettner, 2001; Zheng et al., 1998), altering the function of a protein and, thereby, enabling it to respond sensitively to the reduction potential of a particular redox couple or to the production of a particular ROS. Although structural alterations brought about by these modifications can potentially have a major effect on protein function, in only a few cases have detailed structural analyses shown clearly how this occurs. To be effective signals, these thiol alterations must be readily reversible. This is achieved by the glutathione-reductase–GSH–glutaredoxin (Grx2) system or by the thioredoxin reductase (TrxR2)–Trx2 system that is present in the mitochondrial matrix (Dalle-Donne et al., 2009; Hurd et al., 2005a; Hurd et al., 2005b; Schafer and Buettner, 2001).
Protein thiols can be modified by a direct reaction with H2O2, independently of bulk changes to the redox state of thiol pools. Alternatively, protein thiol modifications can occur through reactions with another thiol–disulphide redox couple. An example of this is the change in the extent of glutathionylation of particular protein thiols in response to changes in the ratio of glutathione to glutathione disulphide (GSH:GSSG), mediated by Grx2 (Costa et al., 2003; Schafer and Buettner, 2001; Beer et al., 2004). However, as this process requires the GSH pool to be significantly oxidised, this situation probably does not occur under most physiological conditions. Alterations to the redox state of Trx2 might also lead to further modifications to protein thiols, provided that a sufficiently oxidised reduction potential can be achieved by the Trx2 pool. More generally, other dithiol proteins – such as peroxidases with appropriate reduction potentials relative to both oxidants and target proteins – can affect the activity of target proteins by introducing internal disulphides (Delaunay et al., 2002).
There are other potential modes of redox signalling in addition to the reversible modification of protein thiols. Proteins can be modified irreversibly by the alkylation of thiols. This is exemplified in the cytosolic pathway of nuclear factor erythroid 2-related factor 2 (NRF2) and Kelch-like ECH-associated protein 1 (KEAP1) (NRF2–KEAP1 pathway), in which one of the KEAP1 thiol groups can react irreversibly with electrophiles to release the NRF2 transcription factor. NRF2 then translocates to the nucleus where it induces transcription of genes under the control of promoters that contain the antioxidant response element (ARE) (Hayes et al., 2010; Kobayashi and Yamamoto, 2006). Alternatively, other interactions are possible, such as the competition of NO with O2 in binding to respiratory complex IV and, thus, altering mitochondrial respiration and the redox state of the respiratory chain (Brown, 1995; Moncada and Erusalimsky, 2002). These and other modes of redox signalling might complement or extend the central role of reversible thiol oxidation.
Biologically important mitochondrial redox signals
The concept of redox signalling in biology initially emerged from studies on ROS production from NOXs and on the interactions of NO with biological systems (reviewed by, Finkel, 2011; Rhee, 2006; Janssen-Heininger et al., 2008). Since then, mitochondria have emerged as an important node of redox signalling in numerous biologically important areas. Among the most intriguing is the role of mitochondrial ROS in O2 sensing, especially during hypoxia (Guzy and Schumacker, 2006; Guzy et al., 2008; Patten et al., 2010; Brunelle et al., 2005). In this process, it seems that the production of O2·− by the respiratory chain increases under conditions of low O2 levels (Chandel et al., 1998; Chandel et al., 2000; Guzy et al., 2005). The site of the O2·− production is thought to be respiratory complex III, but the mechanism is unclear (Chandel et al., 2000; Guzy et al., 2005). The elevated mitochondrial O2·− is converted to H2O2 in the mitochondrial matrix, followed by diffusion into the cytosol where it stabilises hypoxia-inducible factor-1α (HIF-1α), thus leading to the transcription of genes that enable the cell to respond to hypoxia (Sanjuán-Pla et al., 2005). Redox signalling by mitochondrial ROS is now implicated in a disparate range of biologically important areas, including as a determinant of chronological lifespan (the time cells in a stationary phase culture remain viable) in yeast (Bonawitz et al., 2007; Pan et al., 2011; Bell et al., 2007), a factor controlling lifespan in Caenorhabditis elegans (Lee et al., 2010; Yang and Hekimi, 2010; Schulz et al., 2007; Hekimi et al., 2011), in the regulation of the immune system (West et al., 2011; Zhou et al., 2011; Wang et al., 2010), in angiotensin II signalling (Dai et al., 2011), in insulin secretion (Leloup et al., 2009) and mitochondrial homeostasis (St-Pierre et al., 2006).
How to investigate redox signalling pathways
Although there is considerable evidence indicating the importance of mitochondrial redox signalling, changes in ROS concentration or a thiol modification also occur during pathologies. Consequently, it is imperative not to assume that such events are necessarily evidence of a redox signal, and to show that changes in the levels of a particular ROS and the subsequent modification of target proteins correlate with and are sufficient to explain the biological modification. However, assessing changes in ROS and protein redox modifications in biological systems is technically demanding and requires an understanding of the underlying chemistry (Murphy et al., 2011). Despite this, considerable evidence demonstrates the presence of protein thiols within mitochondria that can be modified by H2O2 and S-nitrosating agents (Chouchani et al., 2010; Hurd et al., 2005a; Hurd et al., 2005b; Hurd et al., 2007; Prime et al., 2009; Sun et al., 2007). There are now a variety of methods that can be used to assess the levels of particular ROS within mitochondria, and these include mitochondria-targeted small-molecule fluorescence probes (Dickinson et al., 2010a; Dickinson et al., 2010b; Robinson et al., 2006), the use of mitochondria-targeted proteins derived from green fluorescent protein – whose fluorescence is redox sensitive (Meyer and Dick, 2010), and mitochondria-targeted mass spectrometry probes that enable mitochondrial ROS levels to be estimated in vivo (Cochemé et al., 2011). The proteins modified and the nature of the thiol modification can also be determined by using a number of redox proteomic techniques (Chouchani et al., 2010; Dahm et al., 2006; Danielson et al., 2011; Taylor et al., 2003; Held et al., 2010; Hurd et al., 2007).
Once the involved cysteine residues have been determined it is vital to quantify the extent of the modification to ensure that it correlates with a change in protein activity that is sufficient to account for the phenotypic change (Murphy et al., 2011). Mass spectrometric techniques to assess this are now available (Danielson et al., 2011; Held et al., 2010). Proteomic approaches have also been extended to in-vivo models and a range of mitochondrial proteins have been identified that have reversible modifications (Burwell et al., 2006; Doulias et al., 2010; Charles et al., 2007; Fratelli et al., 2003; Murray et al., 2011; Schroder and Eaton, 2008; Sun and Murphy, 2010; Nadtochiy et al., 2007). Without such measurements it might be that the changes in the level of the putative signalling ROS and in the protein redox modification merely correlate with the change in activity, rather than cause it.
There is increased recognition that protein modifications that are induced by certain ROS, such as H2O2 and NO, are not solely damaging events in biological systems, but might also be important components of feedback and signalling pathways. Mitochondria are at the heart of metabolism and cell death and are, therefore, important for many physiological pathways. It is also clear that ROS and redox modifications of proteins enable mitochondria to respond to and modulate function(s) of cells and whole organisms. However, despite the development of a more nuanced view of the role of ROS and redox modification in biology, caution is still warranted. This is owing to the technical difficulties in measuring and quantifying ROS and protein redox modifications in biological systems. Consequently, it is important to make sure that any changes measured are responsible for the biological changes and are not merely correlates with no signalling function – such as a response to damage or a repair process.
Often redox signalling is compared, explicitly or tacitly, with signalling by reversible protein phosphorylation. However, it is important to bear in mind that with phosphorylation there is a large thermodynamic driving force for the modification of serine, threonine or tyrosine residues that is channelled and kinetically controlled by tightly regulated kinases. The introduction of a bulky, charged phosphate group has a significant effect on the target protein, resulting in a change in its function or location. The reversal of the modification is also tightly regulated by specific phosphatases. Few redox signalling pathways are as well-defined as established phosphorylation signalling pathways, with most only matching a few aspects. Often, the processes that lead to the redox modifications are less specific as there is no kinase equivalent that can selectively modify proteins, with thiol sensitivity usually owing to the influence of local sequence and structural motifs on the pKa and reactivity of the thiol. Consequently, many thiols are susceptible to redox modification, but only a few are important in genuine signalling pathways. This can lead to all redox changes being interpreted as signalling events through a kind of ‘phosphorylation envy’ that has to be guarded against, so the true significance of redox signalling and modifications in mitochondrial biology can emerge.
This article is part of a Minifocus on Mitochondria. For further reading, please see related articles: ‘PINK1 and Parkin-mediated mitophagy at a glance’ by Seok M. Jin and Richard J. Youle (J. Cell Sci.125, 795-799) and ‘Mitochondria and cell signalling’ by Stephen Tait and Douglas Green (J. Cell Sci.125, 807-815).
This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.